REGENERON PHARMACEUTICALS, INC. Interest Expense
REGENERON PHARMACEUTICALS, INC. (REGN) reported Interest Expense of $16.10 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-02
- REGENERON PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-03-31 was $16.10M, a 10.56% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-12-31 was $18.30M, a 5.17% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $17.80M, a 16.34% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-06-30 was $18.90M, a 44.27% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. interest expense for fiscal 2023 was $73.00M, a 22.90% increase from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $59.40M, a 3.66% increase from fiscal 2021.
- REGENERON PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $57.30M, a 0.70% increase from fiscal 2020.
- REGENERON PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $56.90M, a 88.41% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | $16.10M 10-Q · filed 2024-05-02 | $34.40M derived: sum of 2 quarters · filed 2024-05-02 | $52.20M derived: sum of 3 quarters · filed 2024-05-02 | $71.10M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2023-12-31 | $18.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $36.10M derived: sum of 2 quarters · filed 2024-02-05 | $55.00M derived: sum of 3 quarters · filed 2024-02-05 | $73.00M 10-K · filed 2024-02-05 | |||
| 2023-09-30 | $17.80M 10-Q · filed 2023-11-02 | $36.70M derived: sum of 2 quarters · filed 2023-11-02 | $54.70M 10-Q · filed 2023-11-02 | $72.10M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2023-06-30 | $18.90M 10-Q · filed 2023-08-03 | $36.90M 10-Q · filed 2023-08-03 | $54.30M derived: sum of 3 quarters · filed 2024-05-02 | $69.60M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2023-03-31 | $18.00M 10-Q · filed 2024-05-02 | $35.40M derived: sum of 2 quarters · filed 2024-05-02 | $50.70M derived: sum of 3 quarters · filed 2024-05-02 | $63.80M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $17.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $32.70M derived: sum of 2 quarters · filed 2024-02-05 | $45.80M derived: sum of 3 quarters · filed 2024-02-05 | $59.40M 10-K · filed 2024-02-05 | |||
| 2022-09-30 | $15.30M 10-Q · filed 2023-11-02 | $28.40M derived: sum of 2 quarters · filed 2023-11-02 | $42.00M 10-Q · filed 2023-11-02 | $56.10M derived: sum of 4 quarters · filed 2024-02-05 | |||
| 2022-06-30 | $13.10M 10-Q · filed 2023-08-03 | $26.70M 10-Q · filed 2023-08-03 | $40.80M derived: sum of 3 quarters · filed 2024-02-05 | $55.00M derived: sum of 4 quarters · filed 2024-02-05 | |||
| 2022-03-31 | $13.60M 10-Q · filed 2023-05-04 | $27.70M derived: sum of 2 quarters · filed 2024-02-05 | $41.90M derived: sum of 3 quarters · filed 2024-02-05 | $56.30M derived: sum of 4 quarters · filed 2024-02-05 | |||
| 2021-12-31 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $28.30M derived: sum of 2 quarters · filed 2024-02-05 | $42.70M derived: sum of 3 quarters · filed 2024-02-05 | $57.30M 10-K · filed 2024-02-05 | |||
| 2021-09-30 | $14.20M 10-Q · filed 2022-11-03 | $28.60M derived: sum of 2 quarters · filed 2022-11-03 | $43.20M 10-Q · filed 2022-11-03 | $58.00M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2021-06-30 | $14.40M 10-Q · filed 2022-08-03 | $29.00M 10-Q · filed 2022-08-03 | $43.80M derived: sum of 3 quarters · filed 2023-02-06 | $70.10M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2021-03-31 | $14.60M 10-Q · filed 2022-05-04 | $29.40M derived: sum of 2 quarters · filed 2023-02-06 | $55.70M derived: sum of 3 quarters · filed 2023-02-06 | $65.40M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2020-12-31 | $14.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $41.10M derived: sum of 2 quarters · filed 2023-02-06 | $50.80M derived: sum of 3 quarters · filed 2023-02-06 | $56.90M 10-K · filed 2023-02-06 | |||
| 2020-09-30 | $26.30M 10-Q · filed 2021-11-04 | $36.00M derived: sum of 2 quarters · filed 2021-11-04 | $42.10M 10-Q · filed 2021-11-04 | $48.80M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-06-30 | $9.70M 10-Q · filed 2021-08-05 | $15.80M 10-Q · filed 2021-08-05 | $22.50M derived: sum of 3 quarters · filed 2022-02-07 | $30.30M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-03-31 | $6.10M 10-Q · filed 2021-05-06 | $12.80M derived: sum of 2 quarters · filed 2022-02-07 | $20.60M derived: sum of 3 quarters · filed 2022-02-07 | $28.60M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2019-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $14.50M derived: sum of 2 quarters · filed 2022-02-07 | $22.50M derived: sum of 3 quarters · filed 2022-02-07 | $30.20M 10-K · filed 2022-02-07 | |||
| 2019-09-30 | $7.80M 10-Q · filed 2020-11-05 | $15.80M derived: sum of 2 quarters · filed 2020-11-05 | $23.50M 10-Q · filed 2020-11-05 | $30.90M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-06-30 | $8.00M 10-Q · filed 2020-08-05 | $15.70M 10-Q · filed 2020-08-05 | $23.10M derived: sum of 3 quarters · filed 2021-02-08 | $30.50M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-03-31 | $7.70M 10-Q · filed 2020-05-05 | $15.10M derived: sum of 2 quarters · filed 2021-02-08 | $22.50M derived: sum of 3 quarters · filed 2021-02-08 | $29.40M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2018-12-31 | $7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $14.80M derived: sum of 2 quarters · filed 2021-02-08 | $21.70M derived: sum of 3 quarters · filed 2021-02-08 | $28.20M 10-K · filed 2021-02-08 | |||
| 2018-09-30 | $7.40M 10-Q · filed 2019-11-05 | $7.49M 10-Q · filed 2018-11-06 | $14.30M derived: sum of 2 quarters · filed 2019-11-05 | $20.80M 10-Q · filed 2019-11-05 | $20.85M 10-Q · filed 2018-11-06 | $26.72M derived: sum of 4 quarters · filed 2020-02-07 | |
| 2018-06-30 | $6.90M 10-Q · filed 2019-08-06 | $6.92M 10-Q · filed 2018-08-02 | $13.30M 10-Q · filed 2019-08-06 | $13.36M 10-Q · filed 2018-08-02 | $19.32M derived: sum of 3 quarters · filed 2020-02-07 | $25.50M derived: sum of 4 quarters · filed 2020-02-07 | |
| 2018-03-31 | $6.40M 10-Q · filed 2019-05-07 | $6.44M 10-Q · filed 2018-05-03 | $12.42M derived: sum of 2 quarters · filed 2020-02-07 | $18.60M derived: sum of 3 quarters · filed 2020-02-07 | $24.00M derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2017-12-31 | $6.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $12.20M derived: sum of 2 quarters · filed 2020-02-07 | $17.60M derived: sum of 3 quarters · filed 2020-02-07 | $25.10M 10-K · filed 2020-02-07 | |||
| 2017-09-30 | $6.18M 10-Q · filed 2018-11-06 | $11.58M derived: sum of 2 quarters · filed 2018-11-06 | $19.08M 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | $5.40M 10-Q · filed 2018-08-02 | $12.90M 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | $7.50M 10-Q · filed 2018-05-03 | ||||||
| 2016-12-31 | $7.20M 10-K · filed 2019-02-07 | ||||||
| 2015-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $5.32M derived: sum of 2 quarters · filed 2016-02-11 | $8.07M derived: sum of 3 quarters · filed 2016-02-11 | $14.24M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $1.72M 10-Q · filed 2015-11-04 | $4.46M derived: sum of 2 quarters · filed 2015-11-04 | $10.63M 10-Q · filed 2015-11-04 | $16.98M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2015-06-30 | $2.75M 10-Q · filed 2015-08-04 | $8.92M 10-Q · filed 2015-08-04 | $15.27M derived: sum of 3 quarters · filed 2016-02-11 | $24.50M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2015-03-31 | $6.17M 10-Q · filed 2015-05-07 | $12.52M derived: sum of 2 quarters · filed 2016-02-11 | $21.75M derived: sum of 3 quarters · filed 2016-02-11 | $31.93M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-12-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $15.58M derived: sum of 2 quarters · filed 2016-02-11 | $25.76M derived: sum of 3 quarters · filed 2016-02-11 | $37.37M 10-K · filed 2016-02-11 | |||
| 2014-09-30 | $9.23M 10-Q · filed 2015-11-04 | $19.41M derived: sum of 2 quarters · filed 2015-11-04 | $31.02M 10-Q · filed 2015-11-04 | $42.68M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | $10.18M 10-Q · filed 2015-08-04 | $21.79M 10-Q · filed 2015-08-04 | $33.45M derived: sum of 3 quarters · filed 2016-02-11 | $45.19M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-03-31 | $11.61M 10-Q · filed 2015-05-07 | $23.27M derived: sum of 2 quarters · filed 2016-02-11 | $35.01M derived: sum of 3 quarters · filed 2016-02-11 | $46.38M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $23.40M derived: sum of 2 quarters · filed 2016-02-11 | $34.76M derived: sum of 3 quarters · filed 2016-02-11 | $46.44M 10-K · filed 2016-02-11 | |||
| 2013-09-30 | $11.74M 10-Q · filed 2014-11-04 | $23.10M derived: sum of 2 quarters · filed 2014-11-04 | $34.78M 10-Q · filed 2014-11-04 | $46.27M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-06-30 | $11.37M 10-Q · filed 2014-08-05 | $23.04M 10-Q · filed 2014-08-05 | $34.53M derived: sum of 3 quarters · filed 2015-02-12 | $45.95M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-03-31 | $11.68M 10-Q · filed 2014-05-08 | $23.17M derived: sum of 2 quarters · filed 2015-02-12 | $34.58M derived: sum of 3 quarters · filed 2015-02-12 | $45.82M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2012-12-31 | $11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $22.91M derived: sum of 2 quarters · filed 2015-02-12 | $34.14M derived: sum of 3 quarters · filed 2015-02-12 | $45.30M 10-K · filed 2015-02-12 | |||
| 2012-09-30 | $11.41M 10-Q · filed 2013-11-05 | $22.65M derived: sum of 2 quarters · filed 2013-11-05 | $33.81M 10-Q · filed 2013-11-05 | $43.26M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-06-30 | $11.24M 10-Q · filed 2013-08-06 | $22.40M 10-Q · filed 2013-08-06 | $31.85M derived: sum of 3 quarters · filed 2014-02-13 | $35.91M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-03-31 | $11.16M 10-Q · filed 2013-05-03 | $20.61M derived: sum of 2 quarters · filed 2014-02-13 | $24.68M derived: sum of 3 quarters · filed 2014-02-13 | $28.72M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2011-12-31 | $9.46M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $13.52M derived: sum of 2 quarters · filed 2014-02-13 | $17.56M derived: sum of 3 quarters · filed 2014-02-13 | $21.28M 10-K · filed 2014-02-13 | |||
| 2011-09-30 | $4.06M 10-Q · filed 2012-10-24 | $8.11M derived: sum of 2 quarters · filed 2012-10-24 | $11.83M 10-Q · filed 2012-10-24 | $14.29M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $4.05M 10-Q · filed 2012-07-25 | $7.77M 10-Q · filed 2012-07-25 | $10.22M derived: sum of 3 quarters · filed 2013-02-15 | $12.46M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $3.72M 10-Q · filed 2012-04-26 | $6.18M derived: sum of 2 quarters · filed 2013-02-15 | $8.41M derived: sum of 3 quarters · filed 2013-02-15 | $10.75M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $4.69M derived: sum of 2 quarters · filed 2013-02-15 | $7.03M derived: sum of 3 quarters · filed 2013-02-15 | $9.12M 10-K · filed 2013-02-15 | |||
| 2010-09-30 | $2.23M 10-Q · filed 2011-10-27 | $4.58M derived: sum of 2 quarters · filed 2011-10-27 | $6.66M 10-Q · filed 2011-10-27 | $8.42M derived: sum of 4 quarters · filed 2012-02-21 | |||
| 2010-06-30 | $2.34M 10-Q · filed 2011-07-28 | $4.43M 10-Q · filed 2011-07-28 | $6.18M derived: sum of 3 quarters · filed 2012-02-21 | $6.76M derived: sum of 4 quarters · filed 2012-02-21 | |||
| 2010-03-31 | $2.08M 10-Q · filed 2011-05-03 | $3.84M derived: sum of 2 quarters · filed 2012-02-21 | $4.42M derived: sum of 3 quarters · filed 2012-02-21 | $4.42M derived: sum of 4 quarters · filed 2012-02-21 | |||
| 2009-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $2.34M derived: sum of 2 quarters · filed 2012-02-21 | $2.34M derived: sum of 3 quarters · filed 2012-02-21 | $2.34M 10-K · filed 2012-02-21 | |||
| 2009-09-30 | $581.00K 10-Q · filed 2010-10-28 | $581.00K derived: sum of 2 quarters · filed 2010-10-28 | $581.00K 10-Q · filed 2010-10-28 | ||||
| 2009-06-30 | $0.00 10-Q · filed 2010-07-28 | $0.00 10-Q · filed 2010-07-28 | |||||
| 2008-12-31 | $7.75M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |